This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Charles M. Poser, MD
Department of Neurology Harvard Medical School Beth Israel Hospital Boston, MA 02215

Arch Neurol. 1985;42(11):1035.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Conventional teaching for many years has been that the clinical course of multiple sclerosis (MS) can be classified into three groups: relapsing and remitting, progressive from onset, and relapsing and remitting combined with progressive.

During the past several years, however, a great deal of data have accumulated that throw doubt on the usefulness of such categories. I¹ have pointed out that the increasing technological ability to detect asymptomatic lesions raised an important issue regarding the actual time of onset of the disease. More recent findings give emphasis to this problem, calling into question whether exacerbations and remissions are indeed the hallmark of classic MS.

A significant development has been the demonstration that contrastenhanced areas visible by computed tomography (CT) result from alterations of blood-brain barrier impermeability that may be indirectly equated with activity of the disease process.² The anatomic-clinical correlation between such demonstrable lesions and . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?